By Iain Gilbert
Date: Thursday 16 Feb 2023
(Sharecast News) - Shares in pharmaceuticals business Indivior tumbled early on Thursday after the group revealed it had put aside $290.0m for ongoing litigation in the States.
By Iain Gilbert
Date: Wednesday 07 Dec 2022
(Sharecast News) - Pharmaceuticals business Indivior upgraded guidance for the peak annual net revenue potential of its Sublocade asset on Wednesday ahead of its Capital Markets Day event in New York City.
By Frank Prenesti
Date: Monday 14 Nov 2022
(Sharecast News) - UK-based drug company Indivior said it would pay $145m for Opiant Pharmaceuticals which produces treatments to overcome opioid addiction.
Currency | UK Pounds |
Share Price | 1,383.00p |
Change Today | 10.00p |
% Change | 0.73 % |
52 Week High | 1,998.00 |
52 Week Low | 1,360.00 |
Volume | 435,561 |
Shares Issued | 136.32m |
Market Cap | £1,885.24m |
RiskGrade | 314 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
16:38 | 6,721 @ 1,383.00p |
16:38 | 2,657 @ 1,383.00p |
16:38 | 721 @ 1,383.00p |
16:35 | 196,717 @ 1,383.00p |
16:35 | 42 @ 1,383.00p |
CEO | Mark Crossley |
Chair | Graham Hetherington |
You are here: research